HCL Technologies wins deal to become sole IT supplier to Dutch company
DSM is a €9.2-billion health, nutrition and bioscience company in The Netherlands, which restructured its operations last year.
HCL Technologies announced a multi-year deal with DSM, a €9.2-billion health, nutrition and bioscience company in The Netherlands, to modernise its core IT business systems, and move to a product-based IT operating model.
HCL will help accelerate the digital transformation of DSM with a cloud-first strategy, agile delivery and next generation security and network practice. Its Fenix 2.0 digital execution framework will drive best practices and accelerate transformation at scale across DSM’s business units and product lines, according to a HCL Technologies press statement.
HCL plans to enhance IT service delivery for approximately 18,000 end users across 200 sites in more than 50 countries. "This engagement is a testament to our successful track record in working closely with clients to support digital transformation across their business,” said Ashish Kumar Gupta, chief growth officer, Europe and Africa, HCL Technologies.
“We wanted to transition from a multi-vendor landscape and work with a sole integration partner that has the deep expertise to help drive our digital ambitions," said Ipek Ozsuer, chief digital officer of DSM.
In the first quarter ended June 30, 2022, HCL Technologies' CEO and managing director C Vijayakumar cited the DSM deal as an example of HCL Technologies becoming the prime service provider, where the customer is consolidating from many service providers into one core strategic supplier.
Healthcare and life-sciences contributed more than 14 percent of HCL Technologies' $11.5 billion revenue in fiscal year 2022.
